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Abstract
Background: Hepatitis A virus (HAV) is an enteric, viral, infectious disease endemic in many
developing countries such as Madagascar. Infection is often subclinical or asymptomatic in children;
however, symptomatic acute infections become more common with increasing age. In some
developing countries, improvements in living conditions have led to changes in the epidemiological
pattern of HAV infection. There are very few reports on the prevalence of HAV in Madagascar.
This study was to determine the seroprevalence of hepatitis A virus antibodies in relation to age in
the city of Antananarivo, Madagascar.
Methods: Serum samples collected in 2004 during a cross-sectional survey of individuals aged
between two and 24 years from Antananarivo were tested for anti-HAV antibody using a
commercial enzyme immunoassay kit. Subjects were investigated using a standardized social and
medical history questionnaire.
Results: 926 subjects were enrolled including 406 males and 520 females. There were 251 children
under 10 years old and 675 subjects between 10 and 24 years old. Of the 926 serum samples tested,
854 (92.2%) were positive for anti-HAV antibodies. The number of seropositive samples was similar
for males and females. The overall seroprevalence was 83.7% (210/251) for children under 10 years
old and 95.5% (644/675) for subjects aged between 10 and 24 years (p < 0.001).
Conclusion: Despite improvements in sanitary conditions and hygiene over the last few years, the
prevalence of HAV in Antananarivo is high. Only children under five years old remain susceptible
to HAV infection. Immunization against HAV is not needed at the present time in the Madagascan
population, but should be recommended for travellers.
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Background
Hepatitis A virus (HAV) is an epidemiologically impor-
tant virus that causes acute hepatitis in humans. Most
HAV infections are transmitted via the orofecal route,
either by direct contact with an infected person or by
ingestion of contaminated food or water.
Low socioeconomic status, high density housing and
inadequate water treatment contribute to a pattern of high
endemicity in developing countries in which more than
90% of the population has acquired natural immunity
before the age of 10 often from an asymptomatic infec-
tion. In such countries, overt forms of hepatitis A are rela-
tively rare with only exceptional severe cases [1,5]. While
children who become infected are usually asymptomatic
or develop only mild symptoms, adults infected with hep-
atitis A can develop fever, asthenia and jaundice. Immu-
nity to subsequent HAV infection is lifelong.
The epidemiological pattern of hepatitis A infection is cur-
rently changing in many developing countries: improved
sanitary conditions and hygiene practices have reduced
the incidence of HAV infection [1]. However, the widely
asymptomatic and milder forms of infection are underre-
ported and thus the true incidence of hepatitis A is often
underestimated. Thus, the epidemiological pattern of
HAV in a given country is revealed primarily by its sero-
prevalence and only secondarily by disease incidence.
Three epidemiological patterns of endemicity (low, inter-
mediate and high) are observed worldwide. Each pattern
has a different rate of infection, prevailing age of infec-
tion, and transmission model. HAV epidemiological pat-
terns are highly dependent on age and level of hygiene [1-
3]. The distribution of HAV seroprevalence by age group
may reflect current hepatitis A endemicity in countries
and regions.
This study examines HAV seroprevalence in Antanan-
arivo, the largest and most urbanized city in Madagascar.
The aims of this study were to determine the age-specific
seroprevalence of HAV in a young population (between
two and 24 years) according to socioeconomic status and
to detect any potential change in the epidemiological pat-
tern of infection.
Methods
Study design and population
Antananarivo (Commune Urbaine d'Antananarivo or CUA)
is the capital city of Madagascar. located on the central
highlands. According to a report from the civic authorities
(Mairie d'Antananarivo-Ville), CUA had a population of
about 1.5 million in 2004. Antananarivo consists of
administrative, commercial, industrial and residential
areas, with patches of agricultural land that are mostly rice
fields. The city is divided into six administrative districts
(Firaisana).
This was a seroepidemiological study of HAV in individu-
als from Antananarivo, aged between two and 24 years,
based on a descriptive cross-sectional study carried out
during March and May 2004. A two-stage cluster sampling
was used. In the first stage fokontany (the smallest admin-
istrative unit in Madagacar) were randomly sampled. In
the second stage, households in each of these fokontany
were sampled. All family members aged between two and
24 years in the selected households were included.
Informed written consent was obtained from the partici-
pants or the parents of children. The study was conducted
as part of a collaboration between the Ministry of Health
of Madagascar and the Pasteur Institute of Madagascar
and was reviewed and approved by the National Ethical
Committee.
Data Collection
Epidemiological data were collected from questionnaires
and included general information about the target popu-
lation (age, sex, educational level of the head of the
household and socioeconomic characteristics including
the number of siblings, type of residence, water supply,
area of residence) as well as any medical history of jaun-
dice, Hepatitis B immunization or use of traditional med-
icines. Blood samples were collected for HAV serology
Serum samples were tested for IgG antibodies to HAV
using a qualitative enzyme immunoassay kit (Monolisa®
anti-HAV IgM EIA, BIO-RAD, France). Results were read
on a multimode plate reader and were compared with the
optical densities of positive and negative controls.
Statistical analysis
Data were analysed using EPI Info software, Version 6
(Centers for Disease Control and Prevention, Atlanta,
USA). A descriptive analysis was followed by bivariate
analysis using χ2 test or one-factor ANOVA for compari-
son of the various sub-groups with p < 0.05 defined as the
minimal level of significance. Factors with p < 0.20 were
subjected to a multivariate analysis with logistic regres-
sion to determine predictive variables associated with
seroprevalence. Odds ratios and 95% confidence intervals
were calculated and presented for these variables.
Results
The mean age of the 926 subjects was 13.9 years (95%CI
[13.7–14.3]). The sex ratio was 0.78 (406 males/520
females). Of the 926 serum samples analysed for the anti-
HAV (IgG) antibody, 92.2 % (854/926) were positive.
Anti-HAV seroprevalence was measured for the following
age groups: [2–5[, [5–10[, [10–15[, [15–20[and [20–25[.
As Table 1 shows, anti-HAV seropositivity rate increased
with increasing age (Univariate χ2 test for the trend P <BMC Infectious Diseases 2008, 8:78 http://www.biomedcentral.com/1471-2334/8/78
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0.001). Approximately 95.4% of subjects in age groups ≥
10 years were seropositive for anti-HAV antibodies com-
pared with children aged between two and 10 years
(64.6% in [2–5[years and 88.2% in [5–10[years). In chil-
dren aged between five and 10 years old, the anti-HAV
seropositivity rate was more than 90% (Figure 1). Overall,
there was no significant difference (p = 0.16) in the prob-
ability of being anti-HAV seropositive between females
(93.1%) and males (91.1%). The seroprevalence rate was
highly correlated with age, socioeconomic status and
access to clean water and sanitation (Table 1).
Occupation (or parents' occupation in the case of chil-
dren) had a significant effect on a subject's anti-HAV sero-
positivity status. Prevalence was lower (85.5%) in those
with professional occupations than in manual workers
(93.2%). Seroprevalence also varied according to the area
of residence. Subjects living in the 3rd Firaisana  had a
lower prevalence (80.7%, P < 0.01) than those in other
Firaisana (Table 1).
For variables related to the quality of housing (Table 1),
the type of floor (wood, soil, cement versus tiles, parquet,
OR = 2.6, P < 0.01), cooking method (wood, charcoal vs
electric, gas cooker, OR = 3.4, P < 0.01) and shower unit
(absence vs presence, OR 6.3, P < 0.01) were significantly
associated with a higher prevalence of HAV antibodies.
Drinking water supply (Table 1) was also significantly
associated with HAV seroprevalence rate (P < 0.01) but
was more reflective of the overall socioeconomic status of
Table 1: Seroprevalence of antibodies and known risk factors for hepatitis A virus (HAV) in a Madagascan population aged between 
two and 24 years old.
Variable Total, no. (%) HAV + no. (%) Odds ratio (95% CI)* Adjusted Odds Ratio (95% CI)*
Sex
Male 406 (43.8) 370 (91.1) 1
Female 520 (56.2) 484 (93.1) 1.3 (0.8 – 2.1)
Age group
[2–5] years 48 (5.2) 31 (64.6) 1 1
[5–10] years 203 (21.9) 179 (88.2) 4.1 (1.9 – 8.4) 4.7 (2.1 – 10.8)
[10–15] years 248 (26.8) 233 (94.0) 8.5 (3.8 – 18.7) 11.7 (4.8 – 28.4)
[15–20] years 208 (22.5) 197 (94.7) 9.2 (4.2 – 22.9) 15.1 (5.8 – 38.9)
[20–25] years 219 (23.6) 214 (97.7) 23.5 (8.1 – 68.2) 37.7 (11.8 – 120.6)
Occupation
Professional 110 (12.1) 93 (84.5) 1 1
Manual Workers 806 (87.9) 751 (93.2) 2.5 (1.4 – 4.5) 2.0 (1.0 – 4.0)
Area of residence
Firaisana I 220 (23.8) 204 (92.7) 3.1 (1.5 – 6.1)
Firaisana II 131 (14.1) 120 (91.6) 2.6 (1.2 – 5.7)
Firaisana III 109 (11.8) 88 (80.7) 1
Firaisana IV 171 (18.5) 163 (95.3) 4.9 (2.1 – 11.4)
Firaisana V 210 (22.7) 199 (94.8) 4.3 (1.9 – 9.3)
Firaisana VI 85 (9.2) 94,1 (94.1) 3.8 (1.4 – 10.6)
Housing
Cooking method
Electric, gas cooker 188 (20.4) 157 (83.5) 1 1
Wood, Charcoal 732 (79.6) 692 (94.5) 3.4 (2.1 – 5.8) 2.6 (1.4 – 4.8)
Shower unit
Yes 696 (75.2) 628 (90.2) 1 1
No 230 (24.8) 226 (98.3) 6.3 (2.2 – 20.0) 5.0 (1.7 – 14.3)
Floor
Tiles, Parquet 220 (23.9) 190 (86.4) 1 1
Wood, Soil, Cement 698 (76.1) 657 (94.1) 2.6 (1.5 – 4.2) 2.0 (1.1 – 3.6)
Water supply
Taps, Bottle 362 (39.1) 318 (87.6) 1
Communal Fountain 503 (54.3) 480 (95.4) 2.8 (1.7 – 4.8)
River, Well 61 (6.6) 50 (92.6) 1.5 (0.6 – 4.5)
* CI = confidence interval; 1 = reference.BMC Infectious Diseases 2008, 8:78 http://www.biomedcentral.com/1471-2334/8/78
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participants. At the time of study, 93.4% of population
drank for communal water sources (standpipes or drink-
ing fountains). Multivariate analysis confirmed the spe-
cific effects of age and economic factors: occupation,
housing level (type of floor, shower unit, cooking
method). The probability of being anti-HAV seropositive
was significantly higher for subjects ≥ 5 years than for
individuals aged [2–5[years (odds ratio 6.1, 95% CI [2.5–
14.7] for [5–10[years, 14.4 [5.6, 36.8] for [10–15[years,
20.3 [7.2, 57.1] for [15–20[years, 45.4 [13.4–152.9] for
[20–25[years, adjusted for other factors) (Table 1).
Discussion
In Madagascar, available epidemiological data on HAV
infection are limited. This was the first population based
survey of immunity to HAV infections in urban inhabitant
in Madagascar. The overall prevalence of anti-HAV in
inhabitant in Antananarivo under 25 years old was
92.2%. From five years old, the majority of children
(>90%) had natural immunity against HAV. These results
were similar to those of other studies carried out in devel-
oping countries where the epidemiological pattern of
HAV has not changed (6–8). Hepatitis A is endemic to
many regions. However many recent reports indicate a
global change in seroepidemiological patterns of hepatitis
A infection [9,10]. In Delhi (India), seroprevalence in
people younger than 35 years old was similar to that of
the more developed European countries [9]. In Thailand,
the prevalence of anti-HAV was 1.95% in Bangkok and
12.7% in other provinces in people younger than 25 years
[10]. In Italy like in many Western European countries
[11], following the improvement of the standard of living
in the industrialized world, age-specific HAV seropreva-
lence in the general population has decreased steadily and
risk of acquiring HAV infection is high for travellers to
high HAV endemic areas in developing countries.
Typically, improved sanitation facilities are provided in
metropolitan regions first; thus, exposure to HAV remains
more common in rural regions and small cities where it
principally affects the youngest inhabitants. This study in
an urban setting suggested that Antananarivo, and like-
wise Madagascar, were hyperendemic for HAV with very
high infection rates in the first years of life and most of the
population acquiring antibodies to HAV before 10 years
of age. HAV seroprevalence remained high in all age
Prevalence of HAV antibodies according to age in subjects aged between two and 10 years old, Antananarivo 2004 (χ2 test for  trend P < 0.01) Figure 1
Prevalence of HAV antibodies according to age in subjects aged between two and 10 years old, Antananarivo 
2004 (χ2 test for trend P < 0.01).
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groups and changed with age under five years old. This
finding confirmed that the greatest exposure still occurs
early in life and that individuals acquire HAV immunity at
a very young age. In Madagascar a previous study showed
that rural regions have a high seroprevalence of HAV
infection, with an estimated rate of 94.6% [12]. Only in
children younger than 5 years, seroprevalence was higher
in rural area (80%) than in our study in urban area
(64.6%). These results showed that in Madagascar expo-
sure to HAV was probably earlier in rural areas than in
urban areas.
Regarding sociodemographic variables, our findings are
consistent with several previous studies showing a clear
inverse correlation between exposure to HAV and socioe-
conomic level [13-17]. It is well known that HAV infec-
tion is strongly correlated with poverty and inadequate
sanitation. Increasing household income, education,
water quality and quantity, sanitation, and hygiene lead
to decreased HAV prevalence. Indeed, the prevalence of
HAV infection could even be used as an index of the level
of development in a given country. Prevalence of the dis-
ease varies widely, as a consequence of basic sanitation
conditions.
Hepatitis A virus (HAV) is a health problem in countries
where seroepidemiology shows changes from hyperende-
micity to intermediate endemicity [18-21]. Then there are
different patterns with pockets of low prevalence; some
studies indicate a decline of anti-HAV prevalence among
urban children and the possibility of an outbreak of HAV
infection among this population. The infection is pre-
dicted to shift to adulthood with more severe clinical
manifestation in future. Then it is important to determine
the pattern of hepatitis A virus infection in each commu-
nity in order to optimize vaccination strategies: high risk
population for vaccination should be identified. In Mada-
gascar, this study showed that HAV infection was highly
endemic in urban areas. There are no different patterns
between urban and rural areas. But similar seroprevalence
studies must be conducted to detect eventually shifting of
HAV endemicity level in Madagascar in order to introduce
vaccination strategy.
Conclusion
In conclusion, the precocious hepatitis A seroconversion
observed in our study suggests Madagascar may be still
classified among areas of high endemicity. Potential
effects of improvements in hygiene and socioeconomic
conditions in this metropolitan area were not detected.
The inhabitants acquired a lifelong immunity as a result
of natural infection during childhood. These findings do
not support the implementation of mass vaccination but
advocates vaccination of travellers against hepatitis A. The
surveillance of the epidemiological trend of HAV infec-
tion will contribute to the definition of endemicity level
in Madagascar for implementing preventive measures and
for controlling the disease.
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